MENU

International Preterm Birth Industry Meeting Program

November 13-14, 2014

 

Thursday November 13

 

17:00 Posters may be put up in the Drawing Room and remain up throughout the meeting

 

 

18:00 – 18:30

Meet and Greet Reception - Foyer Drawing Room (Main floor)

 

18:30 – 21:00

Banquet – Quebec Room (cost included in registration)

 

 

Session I – The scope of the problem

 

19:30 – Banquet Program

 

Shoo Lee, MBBS FRCPC, PhD Director, Institute of Human Development, Child and Youth Health – the Canadian Institutes of Health Research, Toronto, ON

Welcome, greetings and purpose of the meeting

 

Katharina Staub, President, Canadian Premature Babies Foundation / Fondation pour bébés Prematurés Canadiens, Edmonton, AB

Worldwide prematurity awareness – A parent’s perspective on the need for new diagnostics and therapeutics
View Presentation

 

Diane Kalina, BSc, CDir, Principal, Biocatalyst 4 Development, Toronto, ON

The perplexing gap between commercial opportunity and the problem: Barriers to investment in women’s pregnancy health
View Presentation
 

Friday November 14 (Drawing Room – Main Floor)

 

Session II – Identifying and overcoming barriers

Moderated by Sylvain Chemtob, Universite de Montreal
View Presentation
 

8:00 – 8:25

Mark Johnson, PhD, MRCP, MRCOG Professor and Clinical Chair in Obstetrics, Imperial College, London, UK

Clinical considerations for assessing and treating risk for preterm delivery
View Presentation
 

8:25 – 8:50

Durlin Hickok, MD, MPH, Senior Vice President and Chief Medical Officer, Sera Prognostics, Salt Lake City, UT

Development issues for diagnostics and therapeutics from the industry perspective 
View Presentation
 

8:50 – 9:00

Edward Evantash, MD, Medical Director, Vice President, Medical Affairs, Hologic Inc.

Worldwide market for preterm birth diagnostics and therapeutics
View Presentation
 

9:00 – 9:25

Kim Kamdar, PhD, Partner with Domain Associates (Venture Capital Firm), San Diego, CA

What are the considerations of potential investors in PTB?
View Presentation
 

9:25 – 9:45

Coffee break and poster viewing

 

9:45 – 10:10

Sylvain Chemtob, MD, PhD, Professor, Universite de Montreal, Montreal, QC

New developments in PTB diagnostics and therapeutics – overcoming the barriers
View Presentation
 

10:10 – 10:25

Kristina Adams Waldorf, MD, University of Washington, Seattle, WA

Models for testing therapeutics for preterm labour prevention: the nonhuman primate
View Presentation
 

10:25 – 10:50

Laurence Rulleau, PhD, Vice-President, Business Development, Univalor, Montreal, QC

Commercialization options and issues for the university investigator

 

10:50 – 12:00

Roundtable Discussion – What can be done to solve the dilemma and improve commercial outcomes?

Moderated by Diane Kalina, BSc, CDir, Principal, Biocatalyst4Development, Toronto, ON
View Presentation
 

12:00 – 12:45

Buffet Lunch (cost included in registration)

 

 

Session III – Case studies in preterm birth commercialization

 

12:45 – 14:00

Short descriptions of product or company development by pregnancy and newborn health companies

 

14:00 – 16:00

 

Marketplace Poster Forum

Posters will be invited from international scientists with entrepreneurial ideas for diagnostics, therapeutics and new technologies in PTB; the VCs, regulators, and business development people present will circulate and offer advice or chance for further discussions.

 

16:00

End of meeting